Nivogli 0.3mg Tablet

Nivogli 0.3mg Tablet is a medicine used to treat type 2 diabetes mellitus. It helps control the high blood sugar levels in your body after each meal. It is used when other similar medicines along with a restricted diet, are unable to control abnormally high blood sugar levels.

Nivogli 0.3mg Tablet should be taken just before or along with a meal. The dose and how often you need it will be decided by your doctor so that you get the right amount to control your blood sugar levels. Do not stop taking it suddenly without consulting your doctor. If you do, your blood sugar levels may increase and put you at risk of serious complications like kidney damage and blindness.

This medicine is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Monitor your blood sugar levels regularly while taking this medicine.

The most common side effects of Nivogli 0.3mg Tablet include skin rash, flatulence (gas), stomach pain, and diarrhea. Please consult your doctor if these bother you or do not go away.

This medicine by itself does not cause hypoglycemia (low blood sugar levels). However, when used in combination with other diabetes medicines (especially insulin or sulphonylureas), it can lead to hypoglycemia (low blood sugar levels). Such episodes of hypoglycemia will have to be treated by taking plain glucose. Table sugar or common sugar will not help correct low blood sugar levels if you are taking this medicine.

Before taking it, let your doctor know if you have any kidney or liver problems. Do not take this medicine if you have ulceration or inflammation in the bowel (eg. ulcerative colitis or Crohn's disease). Pregnant or breastfeeding women should also consult their doctor before taking it. Please tell your doctor about all the other medicines you are taking to make sure you are safe. Avoid excessive alcohol intake while taking this medicine as it may increase the risk of hypoglycemia (low blood sugar levels).

• Treatment of Type 2 diabetes mellitus

Treatment of Type 2 diabetes mellitus
Nivogli 0.3mg Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs.
Nivogli 0.3mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Vingose

• Skin rash
• Flatulence
• Abdominal pain
• Diarrhea

Take this medicine in the dose and duration as advised by your doctor. Dissolve it in a glass of water before taking it. Nivogli 0.3mg Tablet is to be taken with food.

Nivogli 0.3mg Tablet is an anti-diabetic medicine. It inhibits the intestinal enzymes responsible for breaking complex sugars into simple sugars such as glucose. This prevents blood glucose levels from rising very high immediately after meals.

• Nivogli 0.3mg Tablet is used together with other diabetes medicines to control blood sugar and avoid long-term complications.

• You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Nivogli 0.3mg Tablet.

• Nivogli 0.3mg Tablet lowers your post-meal blood sugar levels. Therefore, it should be taken before meals.

• Side effects such as stomach pain, gas, and diarrhea may occur during the first few weeks of treatment but should get better with time.

Voglibose [Prescribing Information]. Dehradun, Uttarakhand: Biocon Limited. [Accessed 21 Sept. 2021] (online) Available from:

CiplaMed.Voglibose [Product Index]. [Last reviewed: Aug. 2015]. [Accessed 21 Sept. 2021] (online) Available from:

Pattanaik SR, Shah P, Baker A, et al. Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus. Journal of Clinical and Diagnostic Research. 2018;12(4):OE08-OE12. [Accessed 21 Sept. 2021] (online) Available from:

Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An alpha glucosidase inhibitor. J Clin Diagn Res. 2013;7(12):3023-3027. [Accessed 21 Sept. 2021] (online) Available from:

Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7. [Accessed 12 Mar. 2019] (online) Available from: